The influences of juvenile diabetes on memory and hippocampal plasticity in rats: Improving effects of glucagon-like peptide-1

Neuroscience Research

Volumn 64, Issue 1, 2009, Pages 67-74

  Iwai, Takashi ^a   Suzuki, Manabu ^a   Kobayashi, Kazuma ^a   Mori, Kazuhiro ^a   Mogi, Yasuyuki ^a   Oka, Jun Ichiro ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Glucagon like peptide 1; Juvenile diabetes mellitus; Long term depression; Long term potentiation; NMDA; NR2B

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; ELECTROPHYSIOLOGY; FEMALE; HIPPOCAMPUS; JUVENILE DIABETES MELLITUS; LEARNING DISORDER; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; MEMORY DISORDER; NERVE CELL PLASTICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT TERM MEMORY; SYNAPTIC TRANSMISSION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HIPPOCAMPUS; HYPERGLYCEMIA; LONG-TERM SYNAPTIC DEPRESSION; MALE; MAZE LEARNING; MEMORY DISORDERS; N-METHYLASPARTATE; NEURONAL PLASTICITY; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; STREPTOZOCIN; SYNAPTIC TRANSMISSION;

EID: 64249126355     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.01.013     Document Type: Article

References (44)

1. Allen K.V., Frier B.M., and Strachan M.W. The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur. J. Pharmacol. 490 (2004) 169-175
2. Artola A., Kamal A., Ramakers G.M., Biessels G.J., and Gispen W.H. Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus. Eur. J. Neurosci. 22 (2005) 169-178
3. Biessels G.J., Kamal A., Ramakers G.M., Urban I.J., Spruijt B.M., Erkelens D.W., and Gispen W.H. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 45 (1996) 1259-1266
4. Cabezas C., and Buno W. Distinct transmitter release properties determine differences in short-term plasticity at functional and silent synapses. J. Neurophysiol. 95 (2006) 3024-3034
5. Campos R.V., Lee Y.C., and Drucker D.J. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134 (1994) 2156-2164
6. Chabot C., Massicotte G., Milot M., Trudeau F., and Gagne J. Impaired modulation of AMPA receptors by calcium-dependent processes in streptozotocin-induced diabetic rats. Brain Res. 768 (1997) 249-256
7. Collingridge G.L., and Bliss T.V. Memories of NMDA receptors and LTP. Trends Neurosci. 18 (1995) 54-56
8. During M.J., Cao L., Zuzga D.S., Francis J.S., Fitzsimons H.L., Jiao X., Bland R.J., Klugmann M., Banks W.A., Drucker D.J., and Haile C.N. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med. 9 (2003) 1173-1179
9. Flood J.F., Mooradian A.D., and Morley J.E. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes 39 (1990) 1391-1398
10. Fox M.A., Chen R.S., and Holmes C.S. Gender differences in memory and learning in children with insulin-dependent diabetes mellitus (IDDM) over a 4-year follow-up interval. J. Pediatr. Psychol. 28 (2003) 569-578
11. Gallitano-Mendel A., Izumi Y., Tokuda K., Zorumski C.F., Howell M.P., Muglia L.J., Wozniak D.F., and Milbrandt J. The immediate early gene early growth response gene 3 mediates adaptation to stress and novelty. Neuroscience 148 (2007) 633-643
12. Gispen W.H., and Biessels G.J. Cognition, and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23 (2000) 542-549
13. Goke R., Larsen P.J., Mikkelsen J.D., and Sheikh S.P. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurosci. 7 (1995) 2294-2300
14. Hagen J.W., Barclay C.R., Anderson B.J., Feeman D.J., Segal S.S., Bacon G., and Goldstein G.W. Intellective functioning and strategy use in children with insulin-dependent diabetes mellitus. Child Dev. 61 (1990) 1714-1727
15. Haley T.J., and Mccormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. Chemother. 12 (1957) 12-15
16. Hrabetova S., Serrano P., Blace N., Tse H.W., Skifter D.A., Jane D.E., Monaghan D.T., and Sacktor T.C. Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction. J. Neurosci. 20 (2000) RC81
17. Iwai T., Ito S., Tanimitsu K., Udagawa S., and Oka J.-I. Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes. Neurosci. Res. 55 (2006) 352-360
18. Iwai T., Iinuma Y., Kodani R., and Oka J.-I. Neuromedin U inhibits inflammation-mediated memory impairment and neuronal cell-death in rodents. Neurosci. Res. 61 (2008) 113-119
19. Kamal A., Biessels G.J., Urban I.J., and Gispen W.H. Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression. Neuroscience 90 (1999) 737-745
20. Kamal A., Biessels G.J., Duis S.E., and Gispen W.H. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: interaction of diabetes and ageing. Diabetologia 43 (2000) 500-506
21. Kamei J., Miyata S., Morita K., Saitoh A., and Takeda H. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Pharmacol. Biochem. Behav. 75 (2003) 247-254
22. Katz B., and Miledi R. The role of calcium in neuromuscular facilitation. J. Physiol. 195 (1968) 481-492
23. Kemp A., and Manahan-Vaughan D. Hippocampal long-term depression: master or minion in declarative memory processes?. Trends Neurosci. 30 (2007) 111-118
24. Liu L., Wong T.P., Pozza M.F., Lingenhoehl K., Wang Y., Sheng M., Auberson Y.P., and Wang Y.T. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304 (2004) 1021-1024
25. Massey P.V., Johnson B.E., Moult P.R., Auberson Y.P., Brown M.W., Molnar E., Collingridge G.L., and Bashir Z.I. Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J. Neurosci. 24 (2004) 7821-7828
26. Merchenthaler I., Lane M., and Shughrue P. Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system. J. Comp. Neurol. 403 (1999) 261-280
27. Mojsov S., Weir G.C., and Habener J.F. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79 (1987) 616-619
28. Oka J.-I., Goto N., and Kameyama T. Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus. Neuroreport 10 (1999) 1643-1646
29. Oka J.-I., Suzuki E., and Kondo Y. Endogenous GLP-1 is involved in beta-amyloid protein-induced memory impairment and hippocampal neuronal death in rats. Brain Res. 878 (2000) 194-198
30. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., and Breteler M.M. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53 (1999) 1937-1942
31. Perin-Dureau F., Rachline J., Neyton J., and Paoletti P. Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors. J. Neurosci. 22 (2002) 5955-5965
32. Perry T., Haughey N.J., Mattson M.P., Egan J.M., and Greig N.H. Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4. J. Pharmacol. Exp. Ther. 302 (2002) 881-888
33. Perry T., Lahiri D.K., Sambamurti K., Chen D., Mattson M.P., Egan J.M., and Greig N.H. Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron. J. Neurosci. Res. 72 (2003) 603-612
34. Ramanathan M., Jaiswal A.K., and Bhattacharya S.K. Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats. Psychopharmacology 135 (1998) 361-367
35. Takadera T., Sakamoto Y., and Ohyashiki T. NMDA receptor 2B-selective antagonist ifenprodil-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical neurons. Brain Res. 1020 (2004) 196-203
36. Trudeau F., Gagnon S., and Massicotte G. Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus. Eur. J. Pharmacol. 490 (2004) 177-186
37. Valastro B., Cossette J., Lavoie N., Gagnon S., Trudeau F., and Massicotte G. Up-regulation of glutamate receptors is associated with LTP defects in the early stages of diabetes mellitus. Diabetologia 45 (2002) 642-650
38. Wheeler M.B., Lu M., Dillon J.S., Leng X.H., Chen C., and Boyd III A.E. Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 133 (1993) 57-62
39. Whittemore E.R., Ilyin V.I., and Woodward R.M. Antagonism of N-methyl-d-aspartate receptors by sigma site ligands: potency, subtype-selectivity and mechanisms of inhibition. J. Pharmacol. Exp. Ther. 282 (1997) 326-338
40. Wolters C.A., Yu S.L., Hagen J.W., and Kail R. Short-term memory and strategy use in children with insulin-dependent diabetes mellitus. J. Consult. Clin. Psychol. 64 (1996) 1397-1405
41. Yaka R., He D.Y., Phamluong K., and Ron D. Pituitary adenylate cyclase-activating polypeptide (PACAP(1-38)) enhances N-methyl-d-aspartate receptor function and brain-derived neurotrophic factor expression via RACK1. J. Biol. Chem. 278 (2003) 9630-9638
42. Yoshimura Y., Ohmura T., and Komatsu Y. Two forms of synaptic plasticity with distinct dependence on age, experience, and NMDA receptor subtype in rat visual cortex. J. Neurosci. 23 (2003) 6557-6566
43. Zhang X.X., Bunney B.S., and Shi W.X. Enhancement of NMDA-induced current by the putative NR2B selective antagonist ifenprodil. Synapse 37 (2000) 56-63
44. Zucker R.S. Short-term synaptic plasticity. Annu. Rev. Neurosci. 12 (1989) 13-31